Perform blood cells and fibroblasts biochemical and immuno-labeled investigations ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 265 | Lipodystrophy | 1 |
265. Lipodystrophy
Clinical trials : 112 / Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02056912 (ClinicalTrials.gov) | January 2014 | 24/1/2014 | Identification of a New Gene Involved in Hereditary Lipodystrophy | Identification of a New Gene Involved in Hereditary Lipodystrophy - LIPOGENE | Lipodystrophy | Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene;Biological: Perform blood cells and fibroblasts biochemical and immuno-labeled investigations | University Hospital, Bordeaux | NULL | Completed | 18 Years | N/A | Both | 2 | N/A | France |